Tesevatinib (Standard)
Tesevatinib (Standard) is the analytical standard of Tesevatinib. This product is intended for research and analytical applications. Tesevatinib (XL-647) is an orally available, blood-brain barrier-penetrant inhibitor of the epidermal growth factor receptor (EGFR) . Tesevatinib significantly reduces cellular viability, with IC50 values of 11 nM and 102 nM in GBM12 and GBM6, respectively. Tesevatinib also inhibits HER2 (IC50=16.1 nM), VEGFR2 (IC50=1.5 nM), and Src (IC50=10.3 nM) . Tesevatinib can inhibit tumor proliferation and exhibits antitumor activity[1][2].
Product Specifications
CAS Number
781613-23-8
UNSPSC
12352100
Target
EGFR; Reference Standards; Src; VEGFR
Related Pathways
JAK/STAT Signaling; Others; Protein Tyrosine Kinase/RTK
Field of Research
Cancer
Smiles
[H][C@@]12[C@@](C[C@@H](COC3=CC4=C(C(NC5=C(F)C(Cl)=C(Cl)C=C5)=NC=N4)C=C3OC)C2)([H])CN(C)C1
Molecular Formula
C24H25Cl2FN4O2
Molecular Weight
491.39
References & Citations
Shipping Conditions
Room temperature
Scientific Category
Reference Standards
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
ARPP-21, NT (ARPP21, TARPP, cAMP-regulated phosphoprotein 21, Thymocyte cAMP-regulated phosphoprotein) (Azide free) (HRP) discontinued
ITGB2 (CD18, MFI7, Integrin beta-2, Cell Surface Adhesion Glycoproteins LFA-1/CR3/p150,95 Subunit beta, Complement Receptor C3 Subunit beta) (PE)